Hebei Changshan Biochemical Pharmaceutical Balance Sheet Health
Financial Health criteria checks 2/6
Hebei Changshan Biochemical Pharmaceutical has a total shareholder equity of CN¥1.7B and total debt of CN¥2.0B, which brings its debt-to-equity ratio to 117.1%. Its total assets and total liabilities are CN¥4.7B and CN¥2.9B respectively.
Key information
117.1%
Debt to equity ratio
CN¥2.03b
Debt
Interest coverage ratio | n/a |
Cash | CN¥321.99m |
Equity | CN¥1.74b |
Total liabilities | CN¥2.93b |
Total assets | CN¥4.67b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300255's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥1.9B).
Long Term Liabilities: 300255's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥993.8M).
Debt to Equity History and Analysis
Debt Level: 300255's net debt to equity ratio (98.6%) is considered high.
Reducing Debt: 300255's debt to equity ratio has increased from 34.8% to 117.1% over the past 5 years.
Debt Coverage: 300255's debt is not well covered by operating cash flow (12.2%).
Interest Coverage: Insufficient data to determine if 300255's interest payments on its debt are well covered by EBIT.